Breast health is one of the most closely monitored priorities in women’s preventive care, and HSHS St. Mary’s Hospital Medical Center has built its approach around two fundamental commitments: providing expert breast imaging close to home and ensuring patients receive timely, clear answers. The hospital offers digital mammography—both screening and diagnostic—alongside a full suite of follow-up imaging and biopsy services that allow specialists to evaluate any finding with the precision each situation demands.
One feature distinguishes the experience at St. Mary’s Hospital Medical Center from many other facilities: most women receive their mammogram results before they leave their appointment. For patients who might otherwise spend days anxiously waiting, that single detail transforms the process considerably.
This article examines the breast health services at HSHS St. Mary’s Hospital Medical Center, how the diagnostic pathway connects to commonly encountered conditions like breast density, fibrocystic changes, and benign breast findings, and what patients can expect at each stage.
Breast Health Services Available at HSHS St. Mary’s Hospital Medical Center
The breast health services at HSHS St. Mary’s Hospital Medical Center are organized as a progressive diagnostic pathway. The journey typically begins with mammography—either a routine screening study or a physician-ordered diagnostic exam—and, when a finding warrants closer examination, continues into a range of specialized imaging and procedural services.
The following services are available to patients, covering the full spectrum from initial detection through surgical planning:
- Digital screening mammography for routine breast cancer detection in women without symptoms or concerns
- Diagnostic mammography for evaluation of breast symptoms or abnormal screening results
- Breast ultrasound for targeted assessment of specific areas or findings
- Ultrasound-guided biopsy and fine-needle aspiration (FNA)
- Stereotactic core biopsy for findings identified on mammography
- Breast MRI for comprehensive soft-tissue imaging
- Wire localization to guide surgical excision of non-palpable lesions
- Lymphoscintigraphy and sentinel lymph node mapping for surgical planning
This range of services means that when a finding requires follow-up—whether it is related to breast density, a suspected cyst, or a mass visible on imaging—St. Mary’s Hospital Medical Center can pursue a complete, well-coordinated evaluation without requiring patients to seek care elsewhere.
Breast Density and the Role of Mammography in Detection
Breast density is determined by the ratio of fibrous and glandular tissue to fatty tissue within the breast. It is assessed on every mammogram and is clinically significant for two distinct reasons. First, dense breast tissue appears white on mammographic images—the same appearance as many tumors—which means that findings can be harder to detect in dense backgrounds than they would be in predominantly fatty tissue. Second, scientific evidence has established that higher breast density is itself an independent risk factor for breast cancer, separate from and in addition to the visibility challenge it creates on imaging.
The American College of Radiology uses a four-category classification system—known as BI-RADS breast composition categories—to describe the degree of density in each patient’s results. The table below outlines each category along with its relevant clinical implications, giving patients a clearer understanding of what their results describe:
| BI-RADS Category | Tissue Composition | Clinical Implications for Screening |
|---|---|---|
| A – Almost Entirely Fatty | Very low proportion of dense tissue | Mammography is highly sensitive; findings are generally well-visible |
| B – Scattered Fibroglandular Density | Scattered areas of denser tissue present | Most findings remain detectable on a standard mammogram |
| C – Heterogeneously Dense | Larger regions of dense tissue throughout | Some small findings may be obscured; additional imaging may be warranted |
| D – Extremely Dense | High proportion of dense tissue | Reduced mammographic sensitivity; independently associated with elevated cancer risk |
Understanding where a patient falls within this framework is an important part of interpreting mammogram results accurately. Women in the higher-density categories may find that a follow-up diagnostic mammogram, ultrasound, or another imaging modality provides the additional clarity their results require—each of which is available through the breast health services at HSHS St. Mary’s Hospital Medical Center.
Screening and Diagnostic Mammography at St. Mary’s Hospital Medical Center
HSHS St. Mary’s Hospital Medical Center offers both screening and diagnostic mammography using digital imaging, and understanding the distinction helps patients know what to expect from their appointment.
A screening mammogram is a routine study for women without breast symptoms or concerns. It typically produces two images of each breast and takes approximately 20 minutes to complete. Its purpose is to detect breast cancer when it is still too small to be felt by the patient or a clinician. The American Cancer Society recommends that women at average risk begin annual screening mammograms at age 45 and continue annually through age 54, after which screening every other year is appropriate for women who remain in good health. Women between the ages of 40 and 44 have the option to begin annual screening mammography if they wish to do so.
A diagnostic mammogram, by contrast, is ordered when a patient has breast symptoms—such as a new lump, nipple discharge, or changes in skin texture—or when a screening mammogram has identified an area requiring additional evaluation. Unlike a screening study, a diagnostic mammogram involves additional imaging views that provide the radiologist with the detail needed to characterize the area of concern more thoroughly. When necessary, St. Mary’s Hospital Medical Center can also arrange a surgical consultation on the patient’s behalf.
Fibrocystic Changes, Benign Findings, and the Diagnostic Pathway
The majority of breast findings that prompt additional imaging turn out to be benign. Among the most frequently encountered are fibrocystic changes—a pattern of normal hormonal responsiveness in breast tissue that produces fluid-filled cysts, areas of thickening or fibrosis, and cyclical tenderness—as well as a range of benign solid masses including fibroadenomas, lipomas, and intraductal papillomas.
These conditions are not inherently dangerous, but they do require accurate characterization to distinguish them from findings that might need more active management. Fibrocystic tissue, in particular, can make self-examination less reliable from month to month, because the texture and firmness of the breast shift in response to hormonal fluctuations. Regular imaging provides a consistent, objective baseline that self-examination alone cannot replicate.
When a mammogram reveals an area that warrants further examination—whether it reflects dense tissue, a cyst, a solid mass, or calcifications—the appropriate next step depends on the characteristics of the specific finding. The diagnostic services at HSHS St. Mary’s Hospital Medical Center are structured to follow that evidence at each stage, from imaging through tissue sampling when needed.
The Role of Ultrasound in Evaluating Breast Findings
Breast ultrasound is among the key follow-up tools available at HSHS St. Mary’s Hospital Medical Center, and it plays a particularly important role in the evaluation of findings related to fibrocystic tissue and benign masses. Unlike mammography, ultrasound uses sound waves rather than X-rays and is well-suited to two specific clinical tasks: assessing findings in areas of dense tissue where mammography has limited sensitivity, and differentiating between fluid-filled cysts and solid masses.
This distinction carries real clinical weight. A simple cyst identified on ultrasound is almost invariably benign and rarely requires any intervention beyond periodic observation. A solid mass—depending on its imaging characteristics—may prompt a biopsy recommendation to obtain a pathological diagnosis. By clarifying the nature of a finding at the imaging stage, ultrasound helps direct the next step appropriately: avoiding unnecessary procedures when they are not warranted, and identifying cases where tissue sampling will provide the definitive answer the patient and physician need.
Biopsy Services: Moving From Imaging Finding to Definitive Diagnosis
When imaging alone cannot fully characterize a breast finding, biopsy provides the definitive answer by retrieving a small tissue sample for pathological analysis. HSHS St. Mary’s Hospital Medical Center offers two image-guided biopsy approaches, each matched to different types and locations of findings. Both are performed under local anesthesia as outpatient procedures:
- Ultrasound-guided biopsy and fine-needle aspiration (FNA): Used when a finding is clearly visible on ultrasound, this approach uses real-time imaging to guide the needle precisely to the target. FNA collects a small sample of cells suitable for cytological review, while an ultrasound-guided core needle biopsy retrieves a larger tissue cylinder that provides more material for detailed pathological analysis. This technique is commonly used for cysts, palpable masses, and solid nodules identified on imaging.
- Stereotactic core biopsy: This technique uses mammographic imaging—rather than ultrasound—to localize and sample a finding. It is typically used for microcalcifications or subtle areas of architectural distortion that are visible on the mammogram but not on ultrasound. The patient is positioned on a specialized table, and the mammographic system calculates the precise coordinates of the target tissue before the sample is collected.
A confirmed benign pathology result provides definitive reassurance for both the patient and her physician, closing the question of whether a finding is cause for concern and enabling a clear, well-grounded monitoring plan going forward. For the many women whose biopsied findings turn out to be fibrocystic tissue, a benign cyst, or a fibroadenoma, this outcome replaces ongoing uncertainty with a concrete, manageable picture.
Advanced Services: Breast MRI, Wire Localization, and Sentinel Lymph Node Mapping
For patients whose diagnostic or surgical needs extend beyond mammography, ultrasound, and biopsy, HSHS St. Mary’s Hospital Medical Center provides access to three additional specialized services. Each addresses a distinct point in the diagnostic or surgical process, ensuring continuity of care as a patient’s clinical picture develops.
The following describes the role of each service within the broader breast health pathway:
- Breast MRI: MRI produces highly detailed soft-tissue images using magnetic fields rather than X-rays, making it the most sensitive breast imaging modality currently available. It is used selectively—typically to evaluate findings that remain inconclusive after mammography and ultrasound, to assess the extent of a known finding before surgical planning, or to screen patients whose individual risk profile warrants the additional sensitivity that MRI provides. Because of its high sensitivity, breast MRI is most valuable when its findings will directly influence a clinical decision.
- Wire localization: When a breast finding is visible on imaging but cannot be felt on physical examination—such as a small cluster of calcifications or a non-palpable mass—wire localization ensures that surgeons can remove it with precision. A thin wire is placed into the breast under imaging guidance before surgery, marking the exact target location. The wire then guides the surgeon intraoperatively to the correct site, allowing for accurate excision of the lesion with appropriate surrounding tissue.
- Lymphoscintigraphy and sentinel lymph node mapping: This nuclear medicine procedure is used in the surgical planning phase following a breast cancer diagnosis. A small radioactive tracer is injected near the tumor site, and imaging tracks its movement through the lymphatic system to identify the sentinel lymph node—the first node into which the tumor would drain. This information allows the surgical team to sample the most relevant lymph nodes during the operation, supporting accurate pathological staging while limiting the extent of lymph node removal.
Together, these services extend the breast health pathway at St. Mary’s Hospital Medical Center into the surgical planning phase, covering the full continuum from initial screening through definitive intervention when it is needed.
Scheduling, Preparation, and What to Expect
According to HSHS St. Mary’s Hospital Medical Center, most women can schedule a screening mammogram directly, without first obtaining a physician referral—the hospital manages the physician order on the patient’s behalf. For women experiencing breast symptoms—a new lump, nipple discharge, changes in breast shape or skin texture, or any other concern—the hospital advises consulting a physician before scheduling, as a physician referral is required for a diagnostic mammogram.
Preparing for a mammogram appointment requires only a few straightforward steps. Keeping these in mind helps ensure that the imaging study proceeds efficiently and that results are as clear as possible:
- Wear a comfortable two-piece outfit so that undressing from the waist up is easy and does not require removing a one-piece garment entirely
- Do not apply deodorant, perfume, lotion, or powder to the upper body on the day of the appointment—these substances can appear as white spots on mammogram images and may require the study to be repeated
- Inform the imaging team of any prior breast surgeries, implants, or previous biopsies, so that this history can be taken into account when interpreting the images
For patients concerned about the wait between an appointment and receiving results, the process at HSHS St. Mary’s Hospital Medical Center offers meaningful reassurance: most patients receive their mammogram results before they leave their appointment rather than waiting for a report to arrive through a physician’s office at a later date. That immediacy allows patients to leave with clarity rather than uncertainty.
Conclusion
Breast health requires consistent attention, reliable imaging, and a clear path forward when findings need follow-up. HSHS St. Mary’s Hospital Medical Center addresses each of these needs through a breast health program anchored in digital mammography and supported by a full range of diagnostic and procedural services—from ultrasound and image-guided biopsy through advanced imaging and surgical planning tools.
For women navigating findings related to breast density, fibrocystic tissue, or benign breast conditions, the diagnostic services at St. Mary’s Hospital Medical Center provide the tools needed to reach a well-grounded answer at each step of the process. The ability to move from initial screening through ultrasound, biopsy, MRI, and surgical planning within the same program—combined with same-day mammogram results—positions HSHS St. Mary’s Hospital Medical Center as a well-structured option for women throughout northeast Wisconsin seeking comprehensive breast health care.